Foracort Inhaler is a prescription medication combining budesonide, a corticosteroid that reduces inflammation in the airways, and formoterol, a long-acting bronchodilator that relaxes muscles around the airways. It is designed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients requiring combined therapy. This inhaler helps prevent symptoms such as wheezing, shortness of breath, and chest tightness, supporting improved lung function and quality of life when used regularly under medical supervision.

Features

• Contains budesonide and formoterol fumarate dihydrate
• Delivered via a pressurized metered-dose inhaler (pMDI)
• Available in multiple strength combinations (e.g., 100/6 mcg, 200/6 mcg, 400/6 mcg per puff)
• Designed for twice-daily maintenance therapy
• Features a dose counter to track remaining medication
• Portable and easy to use with proper technique

Benefits

• Provides dual-action therapy targeting both inflammation and bronchoconstriction
• Reduces frequency and severity of asthma and COPD exacerbations
• Improves overall lung function and exercise tolerance
• Enhances quality of life by enabling better symptom control
• Helps decrease reliance on rescue inhalers
• Supports long-term airway health with consistent use

Common use

Foracort Inhaler is commonly prescribed for the maintenance treatment of asthma in patients aged 12 years and older where combination therapy is appropriate. It is also indicated for symptomatic management of COPD, including chronic bronchitis and emphysema, in adults. It is not intended for immediate relief of acute bronchospasm; a fast-acting rescue inhaler should be used for sudden symptoms.

Dosage and direction

The dosage must be individualized based on disease severity and patient response. For asthma: usually 1 or 2 inhalations twice daily. For COPD: typically 2 inhalations twice daily. Shake the inhaler well before each use. Breathe out fully, place the mouthpiece between lips, inhale deeply and slowly while pressing the canister, hold breath for 10 seconds, then exhale slowly. Rinse mouth with water after each use to reduce the risk of oral thrush. Do not exceed the prescribed dose.

Precautions

• Not for relief of acute attacks; always keep a short-acting bronchodilator available.
• Patients should be instructed on proper inhaler technique to ensure effective delivery.
• Systemic effects may occur, particularly at high doses over prolonged periods.
• Caution advised in patients with tuberculosis, fungal, bacterial, or viral infections, or ocular herpes simplex.
• Monitor for increased bronchospasm; discontinue if paradoxical bronchospasm occurs.
• Regular monitoring of height in pediatric patients is recommended due to potential growth suppression.

Contraindications

• Hypersensitivity to budesonide, formoterol, or any component of the formulation.
• Primary treatment of status asthmaticus or other acute episodes where intensive measures are required.
• Not recommended in patients with significantly compromised immune systems, untreated fungal, bacterial, or systemic viral infections.

Possible side effect

Common side effects may include headache, tremor, palpitations, pharyngitis, hoarseness, oral candidiasis, and cough. Less frequently, patients may experience nervousness, nausea, dizziness, muscle cramps, or tachycardia. Rare but serious side effects can include cardiovascular effects, severe allergic reactions, adrenal suppression, reduced bone mineral density, glaucoma, cataracts, and growth suppression in children. Report any unusual or severe symptoms to a healthcare provider promptly.

Drug interaction

Foracort Inhaler may interact with:

• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) – may increase budesonide exposure.
• Beta-blockers – may antagonize effects of formoterol and produce severe bronchospasm.
• Diuretics or corticosteroids – may potentiate hypokalemia or ECG changes.
• MAO inhibitors, tricyclic antidepressants – may potentiate cardiovascular effects.
• Other bronchodilators or sympathomimetic agents – additive effects may increase risk of adverse cardiovascular events.

Missed dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for the missed one. Resume the regular dosing schedule. Consistent use is important for optimal control; setting reminders may help maintain adherence.

Overdose

Overdose may lead to excessive beta-adrenergic stimulation and/or corticosteroid effects. Symptoms can include tachycardia, arrhythmias, tremor, hypertension, hypokalemia, hyperglycemia, and seizures. Corticosteroid overdose may cause systemic effects such as hypertension, edema, or adrenal suppression. Treatment is supportive and symptomatic; cardiac monitoring is recommended. Seek immediate medical attention if overdose is suspected.

Storage

Store at room temperature (15–30°C). Keep the canister away from direct heat, sunlight, and open flame. Do not puncture or incinerate, even when empty. Keep out of reach of children and pets. The inhaler should be discarded after the labeled number of doses have been used or after the expiration date, whichever comes first.

Disclaimer

This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and before starting or changing any medication. Do not disregard or delay seeking medical advice based on content provided here.

Reviews

Clinical studies and patient reports indicate that Foracort Inhaler is effective in improving symptom control and reducing exacerbations in asthma and COPD. Many users report better daily functioning and reduced need for rescue medication. Some note the importance of proper technique for optimal results. Individual experiences may vary; discuss benefits and risks with your healthcare provider.